Site 1 protease aggravates acute kidney injury by promoting tubular epithelial cell ferroptosis through SIRT3-SOD2-mtROS signaling
© 2024 Federation of European Biochemical Societies..
Ischemia/reperfusion (I/R)-induced acute kidney injury (AKI) is a common clinical syndrome with high morbidity and mortality. Ferroptosis, a newly discovered form of oxidative cell death, is involved in the pathogenesis of renal I/R injury; however, the underlying mechanism remains to be explored. Here, we reported that site 1 protease (S1P) promotes ischemic kidney injury by regulating ferroptotic cell death of tubular epithelial cells. S1P abundance was measured in hypoxia/reoxygenation (H/R)-treated Boston University mouse proximal tubular (BUMPT) cells and I/R-induced murine kidney tissue. S1P expression in BUMPT cells and kidneys was initially activated by hypoxic stimulation, accompanied by the ferroptotic response. Blocking S1P blunted H/R-induced ferroptotic cell death, which also restored sirtuin 3 (SIRT3) expression and superoxide dismutase 2 (SOD2) activity in BUMPT cells. Next, inhibition of S1P expression restored I/R-suppressed SIRT3 abundance, SOD2 activity and reduced the elevated level of mitochondria reactive oxygen species (mtROS), which attenuated tubular cell ferroptosis and renal I/R injury. In conclusion, S1P promoted renal tubular epithelial cell ferroptosis under I/R status by activating SIRT3-SOD2-mtROS signaling, thereby accelerating kidney injury. Thus, targeting S1P signaling may serve as a promising strategy for I/R kidney injury.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:291 |
---|---|
Enthalten in: |
The FEBS journal - 291(2024), 7 vom: 15. Apr., Seite 1575-1592 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xie, Shiying [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 04.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/febs.17057 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367338726 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367338726 | ||
003 | DE-627 | ||
005 | 20240415233121.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240120s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/febs.17057 |2 doi | |
028 | 5 | 2 | |a pubmed24n1376.xml |
035 | |a (DE-627)NLM367338726 | ||
035 | |a (NLM)38243371 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xie, Shiying |e verfasserin |4 aut | |
245 | 1 | 0 | |a Site 1 protease aggravates acute kidney injury by promoting tubular epithelial cell ferroptosis through SIRT3-SOD2-mtROS signaling |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.04.2024 | ||
500 | |a Date Revised 15.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024 Federation of European Biochemical Societies. | ||
520 | |a Ischemia/reperfusion (I/R)-induced acute kidney injury (AKI) is a common clinical syndrome with high morbidity and mortality. Ferroptosis, a newly discovered form of oxidative cell death, is involved in the pathogenesis of renal I/R injury; however, the underlying mechanism remains to be explored. Here, we reported that site 1 protease (S1P) promotes ischemic kidney injury by regulating ferroptotic cell death of tubular epithelial cells. S1P abundance was measured in hypoxia/reoxygenation (H/R)-treated Boston University mouse proximal tubular (BUMPT) cells and I/R-induced murine kidney tissue. S1P expression in BUMPT cells and kidneys was initially activated by hypoxic stimulation, accompanied by the ferroptotic response. Blocking S1P blunted H/R-induced ferroptotic cell death, which also restored sirtuin 3 (SIRT3) expression and superoxide dismutase 2 (SOD2) activity in BUMPT cells. Next, inhibition of S1P expression restored I/R-suppressed SIRT3 abundance, SOD2 activity and reduced the elevated level of mitochondria reactive oxygen species (mtROS), which attenuated tubular cell ferroptosis and renal I/R injury. In conclusion, S1P promoted renal tubular epithelial cell ferroptosis under I/R status by activating SIRT3-SOD2-mtROS signaling, thereby accelerating kidney injury. Thus, targeting S1P signaling may serve as a promising strategy for I/R kidney injury | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a acute kidney injury | |
650 | 4 | |a ferroptosis | |
650 | 4 | |a ischemia reperfusion | |
650 | 4 | |a site 1 protease | |
650 | 4 | |a tubular epithelial cell | |
650 | 7 | |a Peptide Hydrolases |2 NLM | |
650 | 7 | |a EC 3.4.- |2 NLM | |
650 | 7 | |a Sirtuin 3 |2 NLM | |
650 | 7 | |a EC 3.5.1.- |2 NLM | |
650 | 7 | |a Superoxide Dismutase |2 NLM | |
650 | 7 | |a EC 1.15.1.1 |2 NLM | |
650 | 7 | |a superoxide dismutase 2 |2 NLM | |
650 | 7 | |a EC 1.15.1.1 |2 NLM | |
650 | 7 | |a S1pr1 protein, mouse |2 NLM | |
650 | 7 | |a membrane-bound transcription factor peptidase, site 1 |2 NLM | |
650 | 7 | |a EC 3.4.21.112 |2 NLM | |
650 | 7 | |a Serine Endopeptidases |2 NLM | |
650 | 7 | |a EC 3.4.21.- |2 NLM | |
650 | 7 | |a Proprotein Convertases |2 NLM | |
650 | 7 | |a EC 3.4.21.- |2 NLM | |
650 | 7 | |a Reactive Oxygen Species |2 NLM | |
700 | 1 | |a Zou, Wei |e verfasserin |4 aut | |
700 | 1 | |a Liu, Sirui |e verfasserin |4 aut | |
700 | 1 | |a Yang, Qinglan |e verfasserin |4 aut | |
700 | 1 | |a Hu, Tiantian |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Wei-Ping |e verfasserin |4 aut | |
700 | 1 | |a Tang, Hua |e verfasserin |4 aut | |
700 | 1 | |a Wang, Cheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The FEBS journal |d 2005 |g 291(2024), 7 vom: 15. Apr., Seite 1575-1592 |w (DE-627)NLM15295631X |x 1742-4658 |7 nnns |
773 | 1 | 8 | |g volume:291 |g year:2024 |g number:7 |g day:15 |g month:04 |g pages:1575-1592 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/febs.17057 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 291 |j 2024 |e 7 |b 15 |c 04 |h 1575-1592 |